Cargando…
Pre-Analytical and Clinical Validation of a Dried Blood Spot Assay for Asymmetric Dimethylarginine and L-Arginine
Asymmetric dimethylarginine (ADMA) inhibits nitric oxide (NO) synthesis. It is a risk marker for cardiovascular events and mortality in patients with cardiometabolic diseases and in population-based studies. Plasma or serum analysis of ADMA may be hampered by pre-analytical sample handling. We valid...
Autores principales: | Hannemann, Juliane, Roskam, Thore I., Eilermann, Ina, Siques, Patricia, Brito, Julio, Böger, Rainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230730/ https://www.ncbi.nlm.nih.gov/pubmed/32283799 http://dx.doi.org/10.3390/jcm9041072 |
Ejemplares similares
-
Long-Term Intermittent Exposure to High Altitude Elevates Asymmetric Dimethylarginine in First Exposed Young Adults
por: Lüneburg, Nicole, et al.
Publicado: (2017) -
Asymmetric Dimethylarginine at Sea Level Is a Predictive Marker of Hypoxic Pulmonary Arterial Hypertension at High Altitude
por: Siques, Patricia, et al.
Publicado: (2019) -
Metabolism of asymmetric dimethylarginine in hypoxia: from bench to bedside
por: Hannemann, Juliane, et al.
Publicado: (2020) -
Diurnal Variation of L-Arginine and the Cardiovascular Risk Markers Asymmetric and Symmetric Dimethylarginine and Homoarginine in Rotating Night Shift Workers and Controls
por: Hannemann, Juliane, et al.
Publicado: (2023) -
Dysregulation of the Nitric Oxide/Dimethylarginine Pathway in Hypoxic Pulmonary Vasoconstriction—Molecular Mechanisms and Clinical Significance
por: Hannemann, Juliane, et al.
Publicado: (2022)